| Code | 5730A | ||||||||||
| MA number | EU/1/13/840/001 | ||||||||||
| Product Form: | sol inf 1x25 ml (10 % IG)+1x1,25 ml (rHuPH20) (liek.inj.skl.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Baxalta Innovations GmbH, Austria | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 16.05.2013 |
| SmPC + PL: |
|
| Dokument: |
|
| Dokument: |
|
| Dokument: |
|
| Dokument: |
|
| Dokument: |
|
| Safety feature | Yes |
| Data update: | 14.02.2022 |